New treatment to tackle main cause of blindness

A new treatment for the leading cause of blindness in Ireland is being put on the market today.

Lucentis is aimed at the one-in-10 Irish people aged 50 and up who develop Wet AMD, a condition that can cause a serious deterioration in vision in less than six months.